| Literature DB >> 35864375 |
Laura Kananen1,2,3, Mikko Hurme4, Alexander Bürkle5, Maria Moreno-Villanueva5, Jürgen Bernhardt6, Florence Debacq-Chainiaux7, Beatrix Grubeck-Loebenstein8, Marco Malavolta9, Andrea Basso9, Francesco Piacenza9, Sebastiano Collino10, Efstathios S Gonos11, Ewa Sikora12, Daniela Gradinaru13, Eugene H J M Jansen14, Martijn E T Dollé14, Michel Salmon15, Wolfgang Stuetz16, Daniela Weber17, Tilman Grune17,18,19, Nicolle Breusing19, Andreas Simm20, Miriam Capri21, Claudio Franceschi21, Eline Slagboom22, Duncan Talbot23, Claude Libert24,25, Jani Raitanen26, Seppo Koskinen27, Tommi Härkänen27, Sari Stenholm28,29, Mika Ala-Korpela30,31,32, Terho Lehtimäki33,34,35, Olli T Raitakari29,36,37, Olavi Ukkola38, Mika Kähönen33,34,39, Marja Jylhä26, Juulia Jylhävä40,26.
Abstract
Circulating cell-free DNA (cf-DNA) has emerged as a promising biomarker of ageing, tissue damage and cellular stress. However, less is known about health behaviours, ageing phenotypes and metabolic processes that lead to elevated cf-DNA levels. We sought to analyse the relationship of circulating cf-DNA level to age, sex, smoking, physical activity, vegetable consumption, ageing phenotypes (physical functioning, the number of diseases, frailty) and an extensive panel of biomarkers including blood and urine metabolites and inflammatory markers in three human cohorts (N = 5385; 17-82 years). The relationships were assessed using correlation statistics, and linear and penalised regressions (the Lasso), also stratified by sex.cf-DNA levels were significantly higher in men than in women, and especially in middle-aged men and women who smoke, and in older more frail individuals. Correlation statistics of biomarker data showed that cf-DNA level was higher with elevated inflammation (C-reactive protein, interleukin-6), and higher levels of homocysteine, and proportion of red blood cells and lower levels of ascorbic acid. Inflammation (C-reactive protein, glycoprotein acetylation), amino acids (isoleucine, leucine, tyrosine), and ketogenesis (3-hydroxybutyrate) were included in the cf-DNA level-related biomarker profiles in at least two of the cohorts.In conclusion, circulating cf-DNA level is different by sex, and related to health behaviour, health decline and metabolic processes common in health and disease. These results can inform future studies where epidemiological and biological pathways of cf-DNA are to be analysed in details, and for studies evaluating cf-DNA as a potential clinical marker.Entities:
Keywords: Biomarker of ageing; Cell-free DNA; Frailty; Health behaviours; Metabolomics; Morbidity
Year: 2022 PMID: 35864375 DOI: 10.1007/s11357-022-00590-8
Source DB: PubMed Journal: Geroscience ISSN: 2509-2723 Impact factor: 7.581